[1] Human Plague - United States, 2015

[2] Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas

[3] Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

[4] Staphylococcus aureus resistant to vancomycin--United States, 2002

[5] A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group

[6] Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns

[7] The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007

[8] Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004

[9] Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

[10] Trends in US hospital admissions for skin and soft tissue infections

[11] Herpes simplex virus type 2 in the United States, 1976 to 1994

[12] Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus

[13] Yersinia pestis--etiologic agent of plague

[14] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

[15] Sleep duration in the United States: a cross-sectional population-based study

[16] Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--selected sites, United States, 2003

[17] Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

[18] Self-reported hepatitis C virus antibody status and risk behavior in young injectors

[19] Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs

[20] Spectrum of disease in persons with human immunodeficiency virus infection in the United States

[21] Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

[22] Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990

[23] Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States

[24] Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study

[25] Personality disorder prevalence in psychiatric outpatients: a systematic literature review

[26] Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)

[27] Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

[28] National surveillance for neonatal herpes simplex virus infections

[29] Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

[30] Epidemiology of human plague in the United States, 1900-2012

[31] Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index

[32] The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

[33] Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005

[34] The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

[35] Tetanus surveillance--United States, 1998--2000

[36] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

[37] Surveillance for acute viral hepatitis - United States, 2007

[38] An international survey of sleeping problems in the general population

[39] Bacterial pyomyositis in the United States

[40] Botulism in the United States: a clinical and epidemiologic review

[41] Maternal drug use in perinatal HIV studies. The Women and Infants Transmission Study

[42] The US Influenza Hospitalization Surveillance Network

[43] Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

[44] Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome

[45] Factors associated with inconsistent sun protection in first-degree relatives of melanoma survivors

[46] Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009

[47] Prevention and treatment of low back pain: evidence, challenges, and promising directions

[48] Prevalence and severity of gingivitis in American adults

[49] Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men

[50] Foodborne botulism in the United States, 1990-2000

[51] Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002

[52] Placenta previa: neonatal death after live births in the United States

[53] Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States

[54] Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

[55] Cancer statistics, 2012

[56] Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis

[57] Rapid detection of foodborne botulism outbreaks facilitated by epidemiological linking of cases: implications for food defense and public health response

[58] Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness

[59] Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

[60] Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA

[61] A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients

[62] Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020